KLK3 and Familial prostate cancer: However, early screening of prostate cancer (PCa) based on serum PSA has been the subject of great controversy due to its insufficient specificity and the risk of overdiagnosis and overtreatment, especially for “PSA gray zone” (total PSA ranging from 4 to 10 ng/ml) suspicious patients (4–6).